Advertisement
Table 1 Baseline characteristics of patients with isolated pulmonary Candida spp. colonization (cohort 1)
| Antifungal therapy (n = 102) | No antifungal therapy (n = 220) | p value | |
|---|---|---|---|
| Age (years) | 69 (57; 76) | 70 (58/78) | 0.354 |
| Sex male, n (%) | 83 (81.4) | 162 (73.6) | 0.16 |
| Discipline, n (%) | |||
| Thoracic and cardiovascular surgery | 52 (50.1) | 90 (40.9) | 0.093 |
| General and visceral surgery | 12 (11.8) | 33 (15.0) | 0.493 |
| Trauma surgery | 9 (8.8) | 29 (13.2) | 0.353 |
| Vascular surgery | 12 (11.8) | 25 (11.4) | 1 |
| Urology | 3 (2.9) | 1 (0.5) | 0.096 |
| Otolaryngology | 0 (0) | 5 (2.3) | 0.183 |
| Pneumology | 3 (2.9) | 4 (1.8) | 0.683 |
| Oral and maxillofacial surgery | 0 (0) | 4 (1.8) | 0.311 |
| Neurosurgery | 3 (2.9) | 20 (9.1) | 0.061 |
| Others | 8 (7.8) | 9 (4.1) | 0.184 |
| Cancer, n (%) | 14 (13.7) | 42 (19.1) | 0.271 |
| Permanent pacemaker, n (%) | 15 (14.7) | 17 (7.7) | 0.071 |
| SAPS II | 47 (39; 55) | 40 (30; 48) | <0.001 |
| SOFA score | 7 (5; 10) | 4.5 (2; 8) | <0.001 |
| Lung | 2 (1; 2) | 1 (1; 2) | 0.437 |
| Thrombocytes | 1 (0; 2) | 0 (0; 2) | 0.015 |
| Liver | 0 (0; 2) | 0 (0; 0) | <0.001 |
| Cardiovascular | 3 (0; 4) | 0 (0; 3) | 0.001 |
| Renal | 1 (0; 2) | 0 (0; 2) | 0.017 |
| Pre-existing pneumonia before enrollment, n (%) | 58 (56.9) | 89 (40.5) | 0.008 |
